Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people taking Wegovy 1.7mg are mid-titration, not yet at their maintenance dose. Average weight loss figures from the STEP 1 trial, published in the New England Journal of Medicine, cover the full 68-week course at 2.4mg — but the weight-loss trajectory at 1.7mg is real and measurable. Semaglutide (the active ingredient in Wegovy) is a prescription-only medicine. A GPhC-registered prescriber must assess your suitability before any dose is supplied or changed, and that applies whether you're sourcing it through the NHS or a private service like nume.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Wegovy's titration ladder runs 0.25mg → 0.5mg → 1.0mg → 1.7mg → 2.4mg, with roughly four weeks at each level before your prescriber moves you up. The 1.7mg dose is the penultimate step. Its job is to push appetite suppression closer to maintenance levels while giving your body another month to adjust. Most people notice a meaningful reduction in hunger by this point.
Weight loss at 1.7mg tends to be stronger than at earlier doses. You can find a fuller picture of how the numbers shift week by week on our page about weekly Wegovy weight loss. The headline figure from clinical trials (roughly 15% average body-weight reduction over 68 weeks) is achieved across the whole programme, with the biggest drops coming once patients reach and settle at 2.4mg. The 2.4mg results page covers those numbers in detail.
What that means practically: if you are losing 0.5–1% of body weight per month at 1.7mg, that is consistent with the trial trajectory. Individual results vary considerably based on starting weight, diet, activity and how long you have been on treatment. A prescriber can tell you whether your own progress is on track, that is a clinical conversation, not a formula.
Wegovy is a prescription-only medicine. Any legitimate private price covers more than the pen itself: you are paying for clinical assessment, a prescription written by a regulated prescriber, the medicine, dispensing and delivery. Wegovy pricing in the UK sits within a reported market range that varies by dose and provider, and that range has shifted since Novo Nordisk adjusted list prices.
Headline prices you see advertised sometimes exclude the consultation fee (charged separately), a prescription fee on top, or a delivery charge. Some services bundle everything; others do not. Worth spending 60 seconds on the GPhC pharmacy register to confirm any online pharmacy you're considering is GPhC-registered before parting with money, it takes less than a minute and is the single most useful check you can do.
The cost of manufacturing Wegovy is sometimes cited to argue prices should be lower. That argument ignores the cold-chain storage, clinical oversight, and regulatory compliance that legitimate dispensing requires.
One transparent price covers the consultation, the prescription, the medicine itself, and free next-working-day DPD delivery in plain packaging. Aftercare is included too: clinical support is available seven days a week. There is no subscription and no auto-renewal. Every repeat order goes back to a prescriber for review before anything is dispatched.
We do not compete on being the cheapest option. That is deliberate. The treatment pathway at nume is built around clinical oversight at every stage, and cutting the price means cutting something, usually the clinical layer. Our clinical team reviews every consultation personally.
There are no discount codes, vouchers or promotional offers at nume. These are prescription medicines. A seller offering them with a promo code and without a proper clinical assessment is a red flag, not a bargain, the MHRA has warned repeatedly about fake or illegally traded weight-loss pens reaching patients who buy through unverified sources. If you see a code being promoted for Wegovy or Mounjaro by an unverified seller, report it via the Yellow Card scheme.
For a prescription medicine taken weekly and titrated over months, price is the wrong starting point. The question that actually protects you is: is this medicine genuine, am I being assessed properly, and will someone clinical be available if something feels off?
The Wegovy overview page covers the full picture of how semaglutide works, what the licensed indications are, and what NICE recommends. If you're still deciding between Wegovy and other options, the general Wegovy weight-loss results page compares the clinical evidence across the programme. For lower-dose reference, the 1mg results page sits alongside the 0.5mg page in the same series.
If you're ready to find out whether you're clinically suitable, our prescribers are the right people to ask.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.